Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

53 results about "Flow sorting" patented technology

Robustness sorting learning method based on multi-objective particle swarm optimization and application thereof

The invention relates to a robustness sorting learning method based on multi-objective particle swarm optimization and an application thereof, and the method comprises the following steps of 1, designing an effective deviation function and a robustness variance function of a sorting model based on a deviation-variance equalization theory, and constructing two optimization performance indexes of sorting learning; step 2, on the basis of a multi-objective particle swarm optimization algorithm framework, iteratively optimizing the two objectives of the effectiveness deviation function and the robustness variance function of the sorting model on the sorting learning data set to train the sorting model so as to generate a sorting model archiving solution set; and step 3, selecting a Pareto optimal sorting model with a maximum net flow sorting value from the sorting model filing solution set generated in the previous step as a trained final sorting model based on the idea of a preference sequence structure assessment method PROMEHEE II in a multi-attribute decision theory. Compared with the prior art, the method has the advantages of improving the overall user satisfaction, enhancing theuser experience and the like.
Owner:JINGGANGSHAN UNIVERSITY

Flue gas desulfuration system for removing tar in desulfurization solution

InactiveCN101822944AAffect qualityImprove steam production efficiencyDispersed particle separationLiquid separationFlue gasBuffer tank
The invention discloses a desulfuration system for removing tar in desulfurization solution, comprising a desulfurizing tower, the desulfurization solution is pumped into a first-grade swirler from the desulfurizing tower, the top flow of the first-grade swirler is connected to a buffer tank, and the bottom flow of the first-grade swirler returns to the desulfurizing tower or is transported to a vacuum belt conveyor; the buffer tank is provided with an overflow position, and overflow flowing out of the overflow position returns to the desulfurizing tower; and seriflux in the buffer tank is pumped into a second-grade swirler, the top flow of the second-grade swirler is connected to a waste water tank, and the bottom flow of the second-grade swirler returns to the desulfurizing tower. In the invention, the desulfurization solution discharged from the desulfurizing tower by the system enters the first-grade swirler to be sorted; the top flow sorted by the first-grade swirler flows through the second-grade swirler to be sorted; finally the top flow of the second-grade swirler which contains most of tar is discharged from the desulfuration system to prevent the tar from affecting desulphurization efficiency, equipment service life and gypsum quality; and the separated waste water containing the tar is transported to a coal yard for humidifying coal and improving boiler steam generating efficiency.
Owner:ZHEJIANG TIANLAN ENVIRONMENTAL PROTECTION TECH

Application of miR-99a as acute myelogenous leukemia stem cell molecular marker

The invention provides an application of miR-99a as an acute myelogenous leukemia stem cell molecular marker and also an application thereof in evaluation of prognosis, disease progression and treatment of the acute myelogenous leukemia. In the application, with flow sorting and real-time fluorescent quantitative PCR technologies as bases and bone marrow miR-99a of leukemia patients as detection objects, through comparison of the expression level between leukemia stem cell and leukemia non-stem cell and the expression level between leukemia stem cell and normal hemopoietic stem cell in the leukemia patients, abnormal high expression of the miR-99a in the leukemia stem cell in relapsed and stubborn patients is found and is related to bad prognosis of the patients, so that the miR-99a, as the marker and molecular target of the leukemia stem cells, is a new molecular marker for prognosis evaluation of the leukemia, and also provides the new molecular target for individual treatment. The application is used for preparing a diagnosis therapy product on the basis of detection on expression of the miR-99a, has important significance and clinical application value for tumor therapy and has wide application prospect.
Owner:INST OF HEMATOLOGY & BLOOD DISEASES HOSPITAL CHINESE ACADEMY OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

High-affinity human monoclonal antibody against yellow fever virus and application thereof

The invention discloses a high-affinity human monoclonal antibody against yellow fever virus and application thereof, and belongs to the technical field of medicines. The high-affinity human monoclonal antibody against yellow fever virus is prepared by the following steps: taking E protein of yellow fever virus expressed in Escherichia coli as an antigen; screening memory B cells which can specifically bind to the E protein of yellow fever virus from PBMCs of a convalescent patient by performing flow sorting, thereby further obtaining variable-region fragments of an antibody; connecting the variable-region fragments of the antibody with a constant region to an expression vector; carrying out expression in mammalian cells, and carrying out purification; and then, carrying out a series of function tests, thereby obtaining 1 strain of the high-affinity human monoclonal antibody against yellow fever virus. The affinity between the antibody and the antigen is 1.49pm; moreover, the antibodyhas very strong yellow fever virus neutralization activity and IC50 at 4ng/ml. In addition, the antibody is capable of completely protecting mice from yellow fever virus at lethal dose. Thus, the high-affinity human monoclonal antibody against yellow fever virus has application values in clinical treatment and prevention of yellow fever virus.
Owner:INST OF MICROBIOLOGY - CHINESE ACAD OF SCI

Method for predicting chemicotherapy sensitivity by using cervical carcinoma side population cell

A disclosed method for predicting chemicotherapy sensitivity by using cervical carcinoma side population cell comprises the following steps: preparing cervical carcinoma cell, and performing in-vitro adherent culture on the cervical carcinoma cell; collecting cervical carcinoma cell at logarithmic phase, and adding the cell into Hoechst33342; sorting SP cells by using a superspeed flow sorting system, and applying SP cell and NSP cell obtained through sorting to further experiment research; and then adding cis-platinum with different concentrations respectively into NSP cell and SP cell, staining by using an Annexin V FITC cell apoptosis detection kit, performing detection by using a flow cytometer, performing different doses of radiotherapy on SP cell and NSP cell, staining by using an Annexin V FITC cell apoptosis detection kit, and performing detection by using a flow cytometer. The cell apoptosis rate is equal to UR% plus LR%. Cervical cancer stem cell screening is performed by taking SP cell as an entry point, chemoradiotherapy sensibility difference and possible mechanism are analyzed, and theoretical basis is provided for researching and developing tumor stem cell resisting medicines, some cytokines interdicting signal path and chemical substances.
Owner:NANTONG TUMOR HOSPITAL

Construction method and application of NK (natural killer) cell activation testing receptor signal path NKG2D fluorescence report system

The invention discloses a construction method and an application of an NK (natural killer) cell activation testing receptor signal path NKG2D fluorescence report system. A human NKG2D extracellular region gene sequence and mouse NKG2D transmembrane region and cytoplasmic region gene sequences are obtained by the aid of PCR (polymerase chain reaction) technology, the human and mouse NKG2D gene sequences are connected together by the aid of overlapping PCR technology, and the constructed human and mouse heterozygous NKG2D sequences are inserted into a pLXSN16E6E7 vector to form a vector pLXSN16E6E7-mhNKG2D. A human DAP12 gene sequence is constructed by the aid of the PCR technology and inserted into the pLXSN16E6E7 vector to form a vector pLXSN16E6E7-hDAP12. Plasmids of the two vectors and helper plasmids pCL-ECO of a retrovirus system are co-transfected with HEK293T cells to obtain virus particles containing reinfected mouse cells 3A9. Cell supernatants containing virus particles infect the cells 3A9, a cell line 12A9 steadily expressing mouse and human infusion NKG2D and human DAP12 is screened out by means of repeated flow sorting and re-culture, and downstream signals of NKG2D can be activated under the stimulus of human NKG2D ligand MICA/MICB, so that green fluorescence emitted by the cells can be detected by GFP (green fluorescent protein) expression.
Owner:CENT SOUTH UNIV

A construction method and application of the nkg2d fluorescent reporter system for testing the receptor signaling pathway of nk cell activation

The invention discloses a construction method and an application of an NK (natural killer) cell activation testing receptor signal path NKG2D fluorescence report system. A human NKG2D extracellular region gene sequence and mouse NKG2D transmembrane region and cytoplasmic region gene sequences are obtained by the aid of PCR (polymerase chain reaction) technology, the human and mouse NKG2D gene sequences are connected together by the aid of overlapping PCR technology, and the constructed human and mouse heterozygous NKG2D sequences are inserted into a pLXSN16E6E7 vector to form a vector pLXSN16E6E7-mhNKG2D. A human DAP12 gene sequence is constructed by the aid of the PCR technology and inserted into the pLXSN16E6E7 vector to form a vector pLXSN16E6E7-hDAP12. Plasmids of the two vectors and helper plasmids pCL-ECO of a retrovirus system are co-transfected with HEK293T cells to obtain virus particles containing reinfected mouse cells 3A9. Cell supernatants containing virus particles infect the cells 3A9, a cell line 12A9 steadily expressing mouse and human infusion NKG2D and human DAP12 is screened out by means of repeated flow sorting and re-culture, and downstream signals of NKG2D can be activated under the stimulus of human NKG2D ligand MICA / MICB, so that green fluorescence emitted by the cells can be detected by GFP (green fluorescent protein) expression.
Owner:CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products